← Back to headlines
AbbVie's Ovarian Cancer Drug Elahere Approved for NHS
AbbVie's ovarian cancer drug, Elahere, has received approval for availability through the National Health Service (NHS).
4 Jun, 11:47 — 4 Jun, 11:47
Sources
Showing 1 of 1 sources
